Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The record history now displays a new site revision, v3.6.4, replacing the previous v3.6.3, signaling a backend or UI update to the page.
    Difference
    0.1%
    Check dated 2026-07-25T05:12:27.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    26 days ago
    Change Detected
    Summary
    The study history shows a new revision entry for version v3.6.3, updating the record from v3.6.2.
    Difference
    0.1%
    Check dated 2026-07-03T13:53:26.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The additions show a new revision entry 'Revision: v3.6.2' and the old 'Revision: v3.6.0' entry was removed. This updates the page's version history but does not alter the underlying study data.
    Difference
    0.1%
    Check dated 2026-06-26T11:31:29.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The study record history now shows that the trial is no longer recruiting participants, and the record has been updated to revision 3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T00:52:53.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    A new revision entry, v3.5.5, appears in the record history. The previous revision, v3.5.4, is removed from the visible list.
    Difference
    0.1%
    Check dated 2026-06-05T00:08:14.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A new platform revision entry (v3.5.4) was added to the page history, signaling an update to the underlying UI, while the previous revision label (v3.5.3) was removed from the list.
    Difference
    0.1%
    Check dated 2026-05-21T14:56:40.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.